Innovating Works
HORIZON-HLTH-2021-CARE-05...
HORIZON-HLTH-2021-CARE-05-01: Enhancing quality of care and patient safety
Sólo fondo perdido 0 €
Comunidad autónoma
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 21-09-2021.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:

Health policymakers use context specific knowledge and evidence to develop inclusive, effective and affordable interventions ensuring patient safety;Health care professionals know how to prevent, identify, evaluate and address risks for patient safety, and use harmonised or standardised patient-centred procedures and practice guidelines for improving patient safety developed in partnership with empowered patients;Health care providers integrate harmonised and standardised practices with personalised treatment schemes;Health care providers use quality assured processes to bridge inter-sectorial gaps in the clinical pathways of patients to improve patient safety;An increased number of health care professionals and patients/citizens adhere to recommendations for improved patient safety. ver más

ExpectedOutcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to some of the following expected outcomes:

Health policymakers use context specific knowledge and evidence to develop inclusive, effective and affordable interventions ensuring patient safety;Health care professionals know how to prevent, identify, evaluate and address risks for patient safety, and use harmonised or standardised patient-centred procedures and practice guidelines for improving patient safety developed in partnership with empowered patients;Health care providers integrate harmonised and standardised practices with personalised treatment schemes;Health care providers use quality assured processes to bridge inter-sectorial gaps in the clinical pathways of patients to improve patient safety;An increased number of health care professionals and patients/citizens adhere to recommendations for improved patient safety.
Scope:Patient safety remains an issue of increasing concern for EU health systems. The Commission estimates that between 8% and 12% of patients admitted to hospitals in the EU suffer from adverse effects of health care[1].

Overall, the most common types of in-hospital adverse effects are operative/surgical related, medication or drug related, and health care associated infections, half of them being preventable[2]. According to the Organisation for Economic Co-operation and Development (OECD), more than 7 million admissions in the OECD countries result from safety lapses in primary and ambulatory care[3]. Diagnostic errors persist throughout all settings of care and contribute to increased risks and harms from the treatment[4]. Therefore, it is necessary to develop and implement coherent quality improvement and patient safety strategies in Europe. Harmonisation and standardisation of health care processes (Guidelines and Standard Operating Procedures) along the continuum of care contribute to improve quality and safety of health services, minimise the risk of errors and at the same time ensure the quality and comparability of health data. It is also a mean to address inequities in health care delivery.

The proposals should take into consideration the already existing EU-funded initiatives in this area and must address in a coherent manner at least three of the following items, but may also contain other research and innovations activities for improving patient safety:

Fill knowledge and practice gaps in quality of care and patient safety, including through harmonisation and standardisation of health care delivery, optimizing inter-sectoral clinical pathways and decision-making processes and tools across regions and countries. Development and piloting of harmonised evidence-based interventions in a uniform and structured way in health care institutions of different EU regions and countries. This should be addressed in case studies at hospital, primary and outpatient care levels, and it should also take into consideration the diverse health care landscape across European Union and Associated Countries. Research on translation of international standards and clinical guidelines into national practice for improved quality of care and patient safety. Provide context-specific evidence on facilitators and barriers for transferring identified good practices across regions and countries. Comprehensive comparison of practices related to clinical guidelines in European Union and Associated Countries, including the regulatory basis underpinning guidelines in each health system, the guideline development process, mechanisms of quality control, implementation modalities, and evaluation of produced recommendations. Development of innovative approaches for the integration of harmonised and standardised practices with personalised treatment plans. Proposals should consider a patient-centred approach that empowers patients/citizens, promotes a culture of dialogue and openness between health professionals and citizens/ patients, and unleashes the potential for social innovation.

The proposals should contribute to improved patient safety along the continuum of care in European Union and Associated Countries. The proposal should present a clear strategy for empowering and involving patients and caregivers in addressing the selected item(s), giving attention to both PROMs (Patient-Reported Outcome Measures) and PREMs (Patient-Reported Experience Measures). The research design, including the expected results, should carefully analyse and tackle the sex and gender dimension. The proposed evidence-based interventions, including clinical guidelines and standards, should meet health care providers’ needs and goals to increase patient safety and health care quality.

All projects funded under this topic are strongly encouraged to participate in networking and joint activities, as appropriate. These networking and joint activities could, for example, involve the participation in joint workshops, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. This could also involve networking and joint activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate. Therefore, proposals are expected to include a budget for the attendance to regular joint meetings and may consider to cover the costs of any other potential joint activities without the prerequisite to detail concrete joint activities at this stage. The details of these joint activities will be defined during the grant agreement preparation phase. In this regard, the Commission may take on the role of facilitator for networking and exchanges, including with relevant stakeholders, if appropriate.


Cross-cutting Priorities:International CooperationSocial InnovationSocio-economic science and humanities


<p id=fn1>[1]Communication from the Commission to the European Parliament and the Council on patient safety, including the prevention and control of healthcare-associated infections (COM (2008) 836).

<p id=fn2>[2]Schwendimann et al., The occurrence, types, consequences and preventability of in-hospital adverse events – a scoping review (BMC Health Services Research (2018) 18:521).

<p id=fn3>[3]The Economics of Patient Safety in Primary and Ambulatory Care: Flying blind (OECD, 2018).

<p id=fn4>[4]Erin P. Balogh et al., Improving Diagnosis in Health Care (The National Academy of Sciences, 2015).

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Comunidad autónoma :
Solo pueden aplicar a esta linea las empresas con sede en:
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración: ¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar como minimo un 100%.
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations. The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.